181 results on '"Walder, Ken"'
Search Results
2. Network-based drug repurposing for schizophrenia
3. Amyloid beta 42 alters cardiac metabolism and impairs cardiac function in male mice with obesity
4. Use of gene regulatory network analysis to repurpose drugs to treat bipolar disorder
5. Effects of antipsychotic drugs on energy metabolism
6. Association of mood disorder and bone health with cognitive function among healthy ageing men
7. Metergoline Shares Properties with Atypical Antipsychotic Drugs Identified by Gene Expression Signature Screen
8. Impact of Mood Disorder History and Bone Health on Cognitive Function Among Men Without Dementia
9. CaMKK2 as an emerging treatment target for bipolar disorder
10. Comorbidity between major depressive disorder and physical diseases: a comprehensive review of epidemiology, mechanisms and management
11. A plasma protein signature associated with cognitive function in men without severe cognitive impairment
12. Leveraging genetic diversity to identify small molecules that reverse mouse skeletal muscle insulin resistance
13. Author Response: Leveraging genetic diversity to identify small molecules that reverse mouse skeletal muscle insulin resistance
14. Leveraging genetic diversity to identify small molecules that reverse mouse skeletal muscle insulin resistance
15. Leveraging genetic diversity to identify small molecules that reverse mouse skeletal muscle insulin resistance
16. Alteration patterns of peripheral concentrations of cytokines and associated inflammatory proteins in acute and chronic stages of schizophrenia: a systematic review and network meta-analysis
17. Use of a gene expression signature to identify trimetazidine for repurposing to treat bipolar depression
18. Minocycline as Treatment for Psychiatric and Neurological Conditions: A Systematic Review and Meta-Analysis
19. Leveraging genetic diversity to identify small molecules that reverse mouse skeletal muscle insulin resistance
20. Adjunctive minocycline for major depressive disorder: A sub-study exploring peripheral immune-inflammatory markers and associated treatment response
21. Identification of reversible and druggable pathways to improve beta-cell function and survival in Type 2 diabetes
22. The role of metformin as a treatment for neuropsychiatric illness
23. Genetic polymorphism in BIN1 rather than APOE is associated with poor recognition memory among men without dementia
24. Class IIa HDACs reprogram mitochondrial metabolism to inhibit apoptosis and ferroptosis in response to lipotoxicity
25. Amyloid beta 42 alters cardiac metabolism and impairs cardiac function in obesity
26. Metformin is Protective Against the Development of Mood Disorders
27. Brain derived neurotrophic factor in perioperative neurocognitive disorders: Current evidence and future directions
28. Repurposing Drugs via Network Analysis: Opportunities for Psychiatric Disorders
29. Integrative Analyses of Transcriptomes to Explore Common Molecular Effects of Antipsychotic Drugs
30. Effects of Psychotropic Drugs on Ribosomal Genes and Protein Synthesis
31. Common effects of bipolar disorder medications on expression quantitative trait loci genes
32. Genetic polymorphism in BIN1 rather than APOE is associated with poor recognition memory among men without dementia
33. Co-Expression Networks Unveiled Long Non-Coding RNAs as Molecular Targets of Drugs Used to Treat Bipolar Disorder
34. Depression and bone loss as risk factors for cognitive decline: A systematic review and meta-analysis
35. Intertwined associations between oxidative and nitrosative stress and endocannabinoid system pathways: Relevance for neuropsychiatric disorders
36. Exploring interleukin-6, lipopolysaccharide-binding protein and brain-derived neurotrophic factor following 12 weeks of adjunctive minocycline treatment for depression
37. Diet and depression: future needs to unlock the potential
38. Beak and feather disease virus and Chlamydiales infections in wild Australian psittacines: no statistical evidence for dependence
39. Baseline serum amino acid levels predict treatment response to augmentation with N-acetylcysteine (NAC) in a bipolar disorder randomised trial
40. Biological Mechanism(s) Underpinning the Association between Antipsychotic Drugs and Weight Gain
41. The lipid paradox in neuroprogressive disorders: Causes and consequences
42. Polyphenols as adjunctive treatments in psychiatric and neurodegenerative disorders: Efficacy, mechanisms of action, and factors influencing inter-individual response
43. The endocannabinoidome in neuropsychiatry: Opportunities and potential risks
44. The cytokine storms of COVID-19, H1N1 influenza, CRS and MAS compared. Can one sized treatment fit all?
45. Mood Regulatory Actions of Active and Sham Nucleus Accumbens Deep Brain Stimulation in Antidepressant Resistant Rats
46. Transcriptional Modulation of the Hippo Signaling Pathway by Drugs Used to Treat Bipolar Disorder and Schizophrenia
47. The role of high-density lipoprotein cholesterol, apolipoprotein A and paraoxonase-1 in the pathophysiology of neuroprogressive disorders
48. The endocannabinoid system and retinoic acid signaling combine to influence bone growth
49. Systemic inflammation and grey matter volume in schizophrenia and bipolar disorder: Moderation by childhood trauma severity
50. Preventing the development of severe COVID-19 by modifying immunothrombosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.